A recent study highlights the occurrence of collapsing glomerulopathy and thrombotic microangiopathy following chimeric antigen receptor T cell therapy. This research adds to the understanding of potential complications associated with CAR T-cell treatments.
collapsing glomerulopathy and thrombotic microangiopathy after chimeric antigen receptor t cell therapy
Original title: “Collapsing Glomerulopathy and Thrombotic Microangiopathy after Chimeric Antigen Receptor T Cell Therapy.”